Venture Capital

Backed by Maria Sharapova, new startup Amulet launches a science-first supplement aiming to optimize women's performance throughout their entire cycle.

Over 2000 leaders will gather for the FNMPC conference, focusing on Indigenous equity ownership in major projects to build generational wealth.

Former Hartbeat CEO Thai Randolph acquires As/Is and Goodful from BuzzFeed, launching a new venture to build legacy brands with creators as equity partners.

With a $1M+ direct-to-player presale and a $100K tournament prize pool, Azuki's 'Gates Awakened' makes a bold entrance into the competitive card game scene.

Acclaimed director Hirokazu Kore-eda receives a prestigious award for his artistic vision and industry advocacy, highlighting a pivotal moment for cinema.

Fresh from bankruptcy, WeWork launches 'WeWork Go' pods for airports and busy hubs. Is this the key to its rebound and the future of work-on-the-go?

With promising Phase 2 data for its novel peptide therapies, Sapience Therapeutics is engaging investors, signaling a critical push for future growth.

With a fresh $12M in funding, Canadian fintech Common Wealth is using AI and a modern platform to bring retirement plans to underserved small businesses.

A new partnership introduces PBSerum®, a biologically inspired enzyme treatment, aiming to redefine skin quality in the multi-billion dollar aesthetics market.

L2L's new Execution AI, built on AWS, promises to move factories from reactive chaos to proactive intelligence, addressing a decade of stagnant output.

A top UK defense data expert moves to the private sector, highlighting the critical role of AI in the growing shadow war of economic espionage.

A new robotic platform with fingertip controls and remote surgery capabilities aims to overcome barriers to life-saving mechanical thrombectomy for stroke.

Ditching the old OEM model for a 'win-win ecosystem,' Chery bets on shared tech and green manufacturing. A global summit will test this bold new vision.

Orca Security partners with distributor TD SYNNEX, shifting its market strategy to rapidly expand access to its AI-powered, agentless cloud security platform.

Replimune halts a promising cancer therapy and cuts jobs after a stunning FDA rejection, citing a 'failed' system and inconsistent regulatory process.

Allogene Therapeutics faces a make-or-break moment as it prepares to unveil crucial trial data for its 'off-the-shelf' cancer therapy, cema-cel.

With a $2.135M financing round complete, Golden Shield Resources turns its focus to permitting its promising Marudi Mountain gold project in Guyana.

A high-level visit to General Atomics signals a major U.S. push for fusion energy, blending private innovation with public funding to win a global race.

A new collaboration between Emporia Research and Definitive Healthcare promises unprecedented accuracy in recruiting healthcare decision-makers for vital research.

The Chinese EV maker released landmark ESG and climate reports, boosting transparency as it navigates tough regulations and mixed investor sentiment.